4//SEC Filing
Breedlove Robert Charles 4
Accession 0000950170-25-113822
CIK 0001783183other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:40 PM ET
Size
5.3 KB
Accession
0000950170-25-113822
Insider Transaction Report
Form 4
Breedlove Robert Charles
Principal Accounting Officer
Transactions
- Sale
Common Stock
2025-09-05$12.09/sh−461$5,573→ 47,931 total
Holdings
- 6,945.4(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0002066645
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:40 PM ET
- Size
- 5.3 KB